Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds
- 1 January 2017
- journal article
- research article
- Published by Elsevier in Biologicals
- Vol. 45, 20-26
Abstract
No abstract availableKeywords
Funding Information
- Kashan University of Medical Sciences (94154)
This publication has 35 references indexed in Scilit:
- Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosaScientific Reports, 2016
- WITHDRAWN: Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: Protective efficacy in a murine burn wound sepsis modelBurns, 2016
- Outbreak of Multi-Drug Resistant Pseudomonas aeruginosa Bloodstream Infection in the Haematology Unit of a South African Academic HospitalPLOS ONE, 2013
- Pseudomonas aeruginosa – a phenomenon of bacterial resistanceJournal of Medical Microbiology, 2009
- Burn Wound InfectionsClinical Microbiology Reviews, 2006
- Role of Motility and Flagellin Glycosylation in the Pathogenesis of Pseudomonas aeruginosa Burn Wound InfectionsInfection and Immunity, 2005
- Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosaTrends in Microbiology, 2004
- Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit — an infection control studyBurns, 2001
- Establishment of infection: lessons from a versatile opportunistMicrobes and Infection, 2000